EUVIMEDEUVIMED entdecken
Crossref

Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema

The Egyptian Journal of Hospital Medicine · 01.01.2026 · 102 (1) · 1296-1304

DOI: 10.21608/ejhm.2026.491923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.01.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema. The Egyptian Journal of Hospital Medicine, 102(1), 1296-1304. https://doi.org/10.21608/ejhm.2026.491923

Vancouver

Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema. The Egyptian Journal of Hospital Medicine. 2026;102(1):1296-1304. doi:10.21608/ejhm.2026.491923

BibTeX
@article{euvimed2026,
  title = {Aflibercept versus Brolucizumab in Resistant Diabetic Macular Edema},
  journal = {The Egyptian Journal of Hospital Medicine},
  year = {2026},
  volume = {102},
  number = {1},
  pages = {1296--1304},
  doi = {10.21608/ejhm.2026.491923}
}
Kostenlos starten →